Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory DyslipidemiasCongenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Hypercholesterolemia, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Nutritional and Metabolic Diseases, familial hypercholesterolemia, hereditary disease, homozygous familial hypercholesterolemia, hyperlipidemia, hyperlipoproteinemia, hyperlipoproteinemia type V, hypertriglyceridemia, inborn errors of metabolism, metabolic diseaseRecruitingPhase 12026-09-18NCT07491172

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
CRISPR Therapeutics AG5

17 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
AotearoaAucklandNew Zealand1
Austin HealthHeidelbergAustralia15
CORE ResearchBrisbaneAustralia1
Duke Early Phase Clinical ResearchDurhamUnited States1
Flourish OrlandoOrlandoUnited States1
Integrity Clinical ResearchHialeahUnited States1
Jacksonville Center for Clinical ResearchJacksonvilleUnited States39
Monash Medical CenterMelbourneAustralia2
NZCRChristchurchNew Zealand1
Oregon Health & Science University (OHSU)PortlandUnited States25
Peters Medical ResearchHigh PointUnited States7
Richmond PharmacologyLondonUnited Kingdom7
Royal AdelaideAdelaideAustralia1
Royal Papworth HospitalCambridgeUnited Kingdom18
Royal Prince Alfred HospitalCamperdownAustralia19
United Medical ResearchPort OrangeUnited States4
University of RochesterRochesterUnited States360